Ensuring best practice in pharma recruitment
Giles Hampson, Managing director at RMG, discusses what should you consider when hiring to ensure best practice in pharma recruitment? Writing as the Managing Director...
Which size of pharma company is the best fit for you?
Artyom Smirnov, Managing consultant at Talentmark, explores which size of pharma company is the best fit for you? Competition for top talent in pharma is...
Is pharma addressing the gender pay gap?
Reporting on the gender pay gap is now a requirement for companies of a certain size. How is pharma addressing the gender pay gap...
Pharma recruitment firm increases contract placements by 250%
An international life sciences recruitment firm has seen an increase in contract placements by 250 per cent year on year with a substantial increase...
Senior appointments strengthen Chugai leadership team in Europe
Chugai Pharma Europe (CPE) have announced that from October 1 2019, Troy Robinson will be appointed as Managing Director of Chugai Pharma Europe and...
Making a career move in pharma
If you feel that you have gone as far as you can in your current role, it could be time to make a career...
How to get into a healthcare agency
Louise Lavelle, Team Lead of Healthcare Communications, Carrot Pharma Recruitment discusses how to get your foot in the door of a healthcare agency and...
Pf Awards 2019: A Bright Future
Shannon Travers won the Best Newcomer Award at the Pf Awards 2019. Here she responds to her win, shares insights into her career and...
Entering the pharmaceutical industry as a graduate
Tom Woods is an ambitious young graduate. Having started his career on a placement at MSD, he has held the roles of student business...
Supporting First Line Field Managers in Pharma
Ian Robinson discusses how to provide structure to sequential in-call coaching to enhance customer excellence when supporting First Line Field Managers in pharma. In the...
Latest articles
Mind the Generation Gap in pharma marketing and market research
Industry came together to explore the impact of the generation gap in pharma marketing and market research at BHBIA's summer event. Different generations have always...
AstraZeneca presents anifrolumab results from Phase III TULIP trial
Results from the positive Phase III TULIP 2 trial for AstraZeneca's anifrolumab, a potential new medicine for the treatment of moderate to severe systemic...
Novartis advanced breast cancer treatment approved in Scotland
Novartis’ Kisqali® (ribociclib) in combination with fulvestrant receives recommendation from Scottish Medicines Consortium as advanced breast cancer treatment for patients with the most common...
Popular articles
NHS Commercial Framework for Medicines consultation published
NHS England has published the NHS Commercial Framework for Medicines for consultation. NHS England has a significant role to play in supporting patient access to...
Mapping NHS change is key to customer engagement
Simon Grime, of Wilmington Healthcare, explains how mapping NHS change through data and intelligence can help industry understand and engage customers in the new...
Pf Power List 2019: Who is shaping the pharma & healthcare sector?
The Pf Power List has looked at who is making a difference in pharma and healthcare in 2019. This year has brought a range of developments...
Medopad and Janssen collaborate on novel digital biomarker for Alzheimer’s disease
Medopad has announced a strategic collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to validate, scale and...
Novartis advanced breast cancer treatment approved in Scotland
Novartis’ Kisqali® (ribociclib) in combination with fulvestrant receives recommendation from Scottish Medicines Consortium as advanced breast cancer treatment for patients with the most common...